Pediatrix Medical Group Reports Mixed Q1 Results Amid Revenue Decline and Expense Reductions

Pediatrix Medical Group, Inc. (NYSE: MD) has released its quarterly results for the period ending March 31, 2025. The company, a leading provider of physician services including newborn and pediatric care, reported mixed results in its income statement and continued to navigate various operational challenges.

• Net Revenue: Decreased to $458.4 million from $495.1 million, a drop of 7.4% year-over-year, primarily due to non-same unit activity from office-based practice exits.
• Same-Unit Revenue: Increased by $26.1 million, or 6.2%, due to better reimbursement rates and increased patient service volumes.
• Operating Expenses: Total operating expenses fell to $426.3 million from $479.2 million, mainly due to reduced practice salaries and benefits as well as a decrease in supplies costs.
• Income from Operations: Rose significantly to $32.1 million from $15.9 million, equating to a 102.0% increase, leading to an operating margin of 7.0%, up from 3.2% the previous year.
• Net Income: Increased to $20.7 million, compared to $4.0 million, resulting in diluted earnings per share of $0.24, compared to $0.05 from the previous year.
• Cash Position: Cash and cash equivalents decreased sharply to $99.0 million from $229.9 million due to operational cash flow adjustments and capital expenditures.
• DSO Improvement: Days Sales Outstanding (DSO) improved to 47.6 days from 52.2 days, reflecting enhanced cash collections from accounts receivable.
• Stock Repurchases: The company repurchased shares to cover withholding tax obligations, with $1.6 million allocated for this purpose.
• Debt Obligations: $400.0 million in unsecured senior notes were outstanding, maturing in 2030, with an interest rate of 5.375%.

Overall, while Pediatrix Medical Group has made strides in reducing its operational expenses and improving profitability, it faces challenges related to revenue declines and liquidity pressures. The decision to exit office-based practices has been a significant part of its strategic refocus, aimed at strengthening hospital-based services.